NDC 58160-812
KINRIX
Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed And Inactivated Poliovirus Vaccine
KINRIX is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Glaxosmithkline Biologicals Sa. The primary component is Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated); Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated); Bordetella Pertussis Filamentous Hemagglutinin Antigen (formaldehyde Inactivated); Bordetella Pertussis Pertactin Antigen (formaldehyde Inactivated); Bordetella Pertussis Toxoid Antigen (formaldehyde, Glutaraldehyde Inactivated); Poliovirus Type 1 Antigen (formaldehyde Inactivated); Poliovirus Type 2 Antigen (formaldehyde Inactivated); Poliovirus Type 3 Antigen (formaldehyde Inactivated).
| Product ID | 58160-812_24ddfd99-cdb4-4eca-8b45-78b143f3b22c |
| NDC | 58160-812 |
| Product Type | Vaccine |
| Proprietary Name | KINRIX |
| Generic Name | Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed And Inactivated Poliovirus Vaccine |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2008-07-09 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125260 |
| Labeler Name | GlaxoSmithKline Biologicals SA |
| Substance Name | CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Active Ingredient Strength | 25 [iU]/.5mL; [iU]/.5mL; [iU]/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL; [iU]/.5mL |
| Pharm Classes | Inactivated Corynebacterium Diphtheriae Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [CS],Diphtheria Toxoid [CS],Inactivated Clostridium Tetani Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [CS],Tetanus Toxoid [CS],Pertussis Vaccine [CS],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [CS],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [CS],Pertussis Vaccine [CS],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Pertussis Vaccine [CS],Vaccines, Inactivated [CS],Inactivated Poliovirus Vaccine [EPC],Actively Acquired Immunity [PE],Poliovirus Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Poliovirus Vaccine [EPC],Actively Acquired Immunity [PE],Poliovirus Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Poliovirus Vaccine [EPC],Actively Acquired Immunity [PE],Poliovirus Vaccines [CS],Vaccines, Inactivated [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
Packaging
NDC 58160-812-52
10 SYRINGE in 1 CARTON (58160-812-52) > .5 mL in 1 SYRINGE (58160-812-43)
| Marketing Start Date | 2008-07-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 58160-812-51 [58160081251]
KINRIX INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125260 |
| Product Type | VACCINE |
| Marketing Start Date | 2010-06-04 |
| Marketing End Date | 2013-06-06 |
NDC 58160-812-52 [58160081252]
KINRIX INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125260 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2010-08-25 |
NDC 58160-812-11 [58160081211]
KINRIX INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125260 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2008-07-09 |
NDC 58160-812-46 [58160081246]
KINRIX INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125260 |
| Product Type | VACCINE |
| Marketing Start Date | 2008-07-09 |
| Marketing End Date | 2013-06-06 |
NDC 58160-812-43 [58160081243]
KINRIX INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125260 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2010-08-25 |
NDC 58160-812-41 [58160081241]
KINRIX INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125260 |
| Product Type | VACCINE |
| Marketing Start Date | 2008-07-09 |
| Marketing End Date | 2013-06-06 |
NDC 58160-812-01 [58160081201]
KINRIX INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125260 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2008-07-09 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) | 25 [iU]/.5mL |
Pharmacological Class
- Inactivated Corynebacterium Diphtheriae Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Vaccines
- Inactivated [CS]
- Diphtheria Toxoid [CS]
- Inactivated Clostridium Tetani Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Vaccines
- Inactivated [CS]
- Tetanus Toxoid [CS]
- Pertussis Vaccine [CS]
- Inactivated Bordetella Pertussis Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Vaccines
- Inactivated [CS]
- Inactivated Bordetella Pertussis Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Vaccines
- Inactivated [CS]
- Pertussis Vaccine [CS]
- Inactivated Bordetella Pertussis Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Pertussis Vaccine [CS]
- Vaccines
- Inactivated [CS]
- Inactivated Poliovirus Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Poliovirus Vaccines [CS]
- Vaccines
- Inactivated [CS]
- Inactivated Poliovirus Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Poliovirus Vaccines [CS]
- Vaccines
- Inactivated [CS]
- Inactivated Poliovirus Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Poliovirus Vaccines [CS]
- Vaccines
- Inactivated [CS]
NDC Crossover Matching brand name "KINRIX" or generic name "Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed And Inactivated Poliovirus Vaccine"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 58160-812 | KINRIX | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine |
| 49281-562 | QUADRACEL | diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine |
| 49281-564 | QUADRACEL | diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine |
Trademark Results [KINRIX]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 KINRIX 77339855 4053321 Live/Registered |
GlaxoSmithKline Biologicals, S.A. 2007-11-29 |
 KINRIX 77339851 3696442 Live/Registered |
GlaxoSmithKline Biologicals, S.A. 2007-11-29 |
 KINRIX 77339669 not registered Dead/Abandoned |
GlaxoSmithKline Biologicals, S.A. 2007-11-29 |
 KINRIX 77009573 3664020 Live/Registered |
GlaxoSmithKline Biologicals S.A. 2006-09-28 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.